PWM
VERA icon

Perigon Wealth Management’s Vera Therapeutics VERA Stock Holding History

Perigon Wealth Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$680K Buy
15,850
+874
+6% +$32.6K 0.01% 743
2026
Q1 		$602K Buy
14,976
+580
+4% +$25K 0.01% 716
2025
Q4 		$729K Buy
14,396
+1,498
+12% +$53.2K 0.01% 645
2025
Q3 		$375K Buy
12,898
+2,492
+24% +$57.6K 0.01% 862
2025
Q2 		$245K Buy
+10,406
New +$234K 0.01% 920

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perigon Wealth Management's VERA Position: Q2 2026 in Review

Perigon Wealth Management increased its Vera Therapeutics (VERA) stake by 5.8% in Q2 2026, buying an estimated $32.6K and bringing the position to 15,850 shares worth $680K. The position accounts for 0.01% of the portfolio, ranked #743.

Perigon Wealth Management first reported a position in VERA in Q2 2025 and has held it in 5 quarters since. The position peaked at $729K in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Perigon Wealth Management held 15,850 shares of Vera Therapeutics worth $680K as of Q2 2026.
  • Perigon Wealth Management bought 874 Vera Therapeutics shares in Q2 2026, an estimated $32.6K.
  • Vera Therapeutics made up 0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #743 holding.
  • Perigon Wealth Management first reported a position in Vera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Perigon Wealth Management's Vera Therapeutics position peaked at $729K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.